Advertisement
Advertisement
U.S. Markets open in 2 hrs 2 mins
Advertisement
Advertisement
Advertisement
Advertisement

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.4800-0.0700 (-1.97%)
At close: 4:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.5500
Open3.4800
Bid3.5500 x 1100
Ask3.6300 x 1000
Day's Range3.4500 - 3.5950
52 Week Range3.2900 - 15.1000
Volume32,997
Avg. Volume120,216
Market Cap59.966M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateJul 05, 2021 - Jul 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.50
  • GlobeNewswire

    Reviva Pharmaceuticals to Present at the Upcoming Benzinga Healthcare Small Cap Conference

    CUPERTINO, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the Benzinga Healthcare Small Cap Conference as well as parti

  • GlobeNewswire

    Reviva Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

    CUPERTINO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the H.C. Wainwright 23rd Annual Global Investment Conference

  • Zacks Small Cap Research

    RVPH: Second Quarter Update

    By John Vandermosten, CFA NASDAQ:RVPH READ THE FULL RVPH RESEARCH REPORT Second Quarter 2021 Financial and Operational Results On August 16, 2021, Reviva Pharmaceutical Holdings, Inc. (NASDAQ: RVPH) presented to investors its second quarter 2021 financial and operational results and filed its Form 10-Q with the SEC. Highlights for the quarter ending June 30, 2021 and to date include: ➢ Report of

Advertisement
Advertisement